Overview
- Includes supplementary material: sn.pub/extras
Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 189)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development.
Editors and Affiliations
Bibliographic Information
Book Title: Antiviral Strategies
Editors: Hans-Georg Kräusslich, Ralf Bartenschlager
Series Title: Handbook of Experimental Pharmacology
DOI: https://doi.org/10.1007/978-3-540-79086-0
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2009
Hardcover ISBN: 978-3-540-79085-3Published: 03 December 2008
Softcover ISBN: 978-3-642-09795-9Published: 30 November 2010
eBook ISBN: 978-3-540-79086-0Published: 02 December 2008
Series ISSN: 0171-2004
Series E-ISSN: 1865-0325
Edition Number: 1
Number of Pages: XI, 379
Number of Illustrations: 32 b/w illustrations, 20 illustrations in colour
Topics: Pharmacology/Toxicology, Virology, Pharmaceutical Sciences/Technology, Drug Resistance, Gene Therapy